Clinical Trial Update: Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports an ongoing Phase 3 study evaluating gemcitabine and cisplatin with or without anlotinib in advanced nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN